|
1
|
Meyerhardt JA and Mayer RJ: Systemic
therapy for colorectal cancer. N Engl J Med. 352:476–487. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar :
|
|
3
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valinezhad Orang A, Safaralizadeh R and
Kazemzadeh-Bavili M: Mechanisms of miRNA-mediated gene regulation
from common downregulation to mRNA-specific upregulation. Int J
Genomics. 2014:9706072014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V and Lee RC: Identification of
microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods
Mol Biol. 265:131–158. 2004.PubMed/NCBI
|
|
7
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amirkhah R, Schmitz U, Linnebacher M,
Wolkenhauer O and Farazmand A: MicroRNA-mRNA interactions in
colorectal cancer and their role in tumor progression. Genes
Chromosomes Cancer. 54:129–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong Y, Yu J and Ng SS: MicroRNA
dysregulation as a prognostic biomarker in colorectal cancer.
Cancer Manag Res. 6:405–422. 2014.PubMed/NCBI
|
|
12
|
Tokarz P and Blasiak J: The role of
microRNA in metastatic colorectal cancer and its significance in
cancer prognosis and treatment. Acta Biochim Pol. 59:467–474.
2012.PubMed/NCBI
|
|
13
|
Khan AP, Poisson LM, Bhat VB, Fermin D,
Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn
GS, Chinnaiyan AM, et al: Quantitative proteomic profiling of
prostate cancer reveals a role for miR-128 in prostate cancer. Mol
Cell Proteomics. 9:298–312. 2010. View Article : Google Scholar :
|
|
14
|
Cui JG, Zhao Y, Sethi P, Li YY, Mahta A,
Culicchia F and Lukiw WJ: Micro-RNA-128 (miRNA-128) down-regulation
in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key
regulators of brain cell proliferation. J Neurooncol. 98:297–304.
2010. View Article : Google Scholar
|
|
15
|
Hauser B, Zhao Y, Pang X, Ling Z, Myers E,
Wang P, Califano J and Gu X: Functions of miRNA-128 on the
regulation of head and neck squamous cell carcinoma growth and
apoptosis. PLoS One. 10:e01163212015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G,
Fu S, Zhang Y, Feng K and Feng Y: microRNA-128 plays a critical
role in human non-small cell lung cancer tumourigenesis,
angiogenesis and lymphangiogenesis by directly targeting vascular
endothelial growth factor-C. Eur J Cancer. 50:2336–2350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Ma B, Ji X, Deng Y, Zhang T, Zhang
X, Gao H, Sun H, Wu H, Chen X, et al: MicroRNA-378-5p suppresses
cell proliferation and induces apoptosis in colorectal cancer cells
by targeting BRAF. Cancer Cell Int. 15:402015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qin J, Wang F, Jiang H, Xu J, Jiang Y and
Wang Z: MicroRNA-145 suppresses cell migration and invasion by
targeting paxillin in human colorectal cancer cells. Int J Clin Exp
Pathol. 8:1328–1340. 2015.PubMed/NCBI
|
|
19
|
Fang Y, Sun B, Xiang J and Chen Z:
MiR-301a promotes colorectal cancer cell growth and invasion by
directly targeting SOCS6. Cell Physiol Biochem. 35:227–236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao HJ, Ren LL, Wang ZH, Sun TT, Yu YN,
Wang YC, Yan TT, Zou W, He J, Zhang Y, et al: MiR-194 deregulation
contributes to colorectal carcinogenesis via targeting AKT2
pathway. Theranostics. 4:1193–1208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takahashi Y, Iwaya T, Sawada G, Kurashige
J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, et al:
Up-regulation of NEK2 by microRNA-128 methylation is associated
with poor prognosis in colorectal cancer. Ann Surg Oncol.
21:205–212. 2014. View Article : Google Scholar
|
|
22
|
Zeng Y: Regulation of the mammalian
nervous system by microRNAs. Mol Pharmacol. 75:259–264. 2009.
View Article : Google Scholar :
|
|
23
|
Papagiannakopoulos T, Friedmann-Morvinski
D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch
DH, Barres BA, et al: Pro-neural miR-128 is a glioma tumor
suppressor that targets mitogenic kinases. Oncogene. 31:1884–1895.
2012. View Article : Google Scholar
|
|
24
|
Adlakha YK and Saini N: MicroRNA-128
downregulates Bax and induces apoptosis in human embryonic kidney
cells. Cell Mol Life Sci. 68:1415–1428. 2011. View Article : Google Scholar
|
|
25
|
Esposito DL, Aru F, Lattanzio R, Morgano
A, Abbondanza M, Malekzadeh R, Bishehsari F, Valanzano R, Russo A,
Piantelli M, et al: The insulin receptor substrate 1 (IRS1) in
intestinal epithelial differentiation and in colorectal cancer.
PLoS One. 7:e361902012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bergmann U, Funatomi H, Kornmann M, Beger
HG and Korc M: Increased expression of insulin receptor substrate-1
in human pancreatic cancer. Biochem Biophys Res Commun.
220:886–890. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dearth RK, Cui X, Kim HJ, Kuiatse I,
Lawrence NA, Zhang X, Divisova J, Britton OL, Mohsin S, Allred DC,
et al: Mammary tumorigenesis and metastasis caused by
overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2.
Mol Cell Biol. 26:9302–9314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baserga R: The contradictions of the
insulin-like growth factor 1 receptor. Oncogene. 19:5574–5581.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Du YY, Lin YF, Chen YT, Yang L,
Wang HJ and Ma D: The cell growth suppressor, mir-126, targets
IRS-1. Biochem Biophys Res Commun. 377:136–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chang KW, Chu TH, Gong NR, Chiang WF, Yang
CC, Liu CJ, Wu CH and Lin SC: miR-370 modulates insulin receptor
substrate-1 expression and inhibits the tumor phenotypes of oral
carcinoma. Oral Dis. 19:611–619. 2013. View Article : Google Scholar
|
|
31
|
Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L
and Dong X: miR-23a-mediated migration/invasion is rescued by its
target, IRS-1, in non-small cell lung cancer cells. J Cancer Res
Clin Oncol. 140:1661–1670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Y, Hu C, Cheng J, Chen B, Ke Q, Lv Z,
Wu J and Zhou Y: MicroRNA-145 suppresses hepatocellular carcinoma
by targeting IRS1 and its downstream Akt signaling. Biochem Biophys
Res Commun. 446:1255–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y,
Qi YT, Xu Q, Li W, Lu B, et al: A regulatory circuit of
miR-148a/152 and DNMT1 in modulating cell transformation and tumor
angiogenesis through IGF-IR and IRS1. J Mol Cell Biol. 5:3–13.
2013. View Article : Google Scholar :
|
|
34
|
Pandurangan AK: Potential targets for
prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt
pathways. Asian Pac J Cancer Prev. 14:2201–2205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Tian H and Wang L: Effects of PTEN
on the proliferation and apoptosis of colorectal cancer cells via
the phosphoinositol-3-kinase/Akt pathway. Oncol Rep. 33:1828–1836.
2015.PubMed/NCBI
|
